151 related articles for article (PubMed ID: 29552627)
1. Primary small cell ovarian cancer of pulmonary type: A case report.
Kalampokas E; Sharma V; Gagliardi T; Payne F; Gurumurthy M
Gynecol Oncol Rep; 2018 May; 24():10-13. PubMed ID: 29552627
[TBL] [Abstract][Full Text] [Related]
2. Small cell carcinoma of the ovary, pulmonary type: A role for adjuvant radiotherapy after carboplatin and etoposide?
Asom AS; Lastra RR; Hasan Y; Weinberg L; Fleming GF; Kurnit KC
Gynecol Oncol Rep; 2022 Feb; 39():100925. PubMed ID: 35059489
[TBL] [Abstract][Full Text] [Related]
3. Primary Ovarian Small Cell Carcinoma of Pulmonary Type: Analysis of 6 Cases and Review of 31 Cases in the Literatures.
Chen X; Liu HL; Wang JS; Zhao FH
Chin Med Sci J; 2023 Jun; 38(2):130-137. PubMed ID: 37286512
[TBL] [Abstract][Full Text] [Related]
4. Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature.
Tsolakidis D; Papanikolaou A; Ktenidis K; Pervana S
Eur J Gynaecol Oncol; 2012; 33(3):312-5. PubMed ID: 22873108
[TBL] [Abstract][Full Text] [Related]
5. Ovarian small cell carcinoma by ovarian torsion feature: A cytopathology challenging case.
Keikha F; Hadizadeh A; Akhavan S; Nili F; Eshghinejad A; Ghaemi M
Int J Surg Case Rep; 2022 Jul; 96():107337. PubMed ID: 35797874
[TBL] [Abstract][Full Text] [Related]
6. The Cytoreductive Effect of Radiotherapy for Small Cell Ovarian Carcinoma of the Pulmonary Type: A Case Report and Review of the Literature.
Terada S; Suzuki T; Hasegawa A; Nakayama S; Adachi H
Case Rep Obstet Gynecol; 2018; 2018():4383216. PubMed ID: 29581906
[TBL] [Abstract][Full Text] [Related]
7. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
[TBL] [Abstract][Full Text] [Related]
8. Optimal chemotherapy treatment for women with recurrent ovarian cancer.
Fung-Kee-Fung M; Oliver T; Elit L; Oza A; Hirte HW; Bryson P
Curr Oncol; 2007 Oct; 14(5):195-208. PubMed ID: 17938703
[TBL] [Abstract][Full Text] [Related]
9. Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC).
Seifert H; Georgiou A; Alexander H; McLachlan J; Bodla S; Kaye S; Barton D; Nobbenhuis M; Gore M; Banerjee S
Gynecol Oncol; 2015 Nov; 139(2):216-20. PubMed ID: 26318078
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature.
Yang X; Chen J; Dong R
J Ovarian Res; 2019 Jul; 12(1):69. PubMed ID: 31345245
[TBL] [Abstract][Full Text] [Related]
12. What Characterizes Long-term Survivors of Recurrent Ovarian Cancer? Case Report and Review of the Literature.
Hilal Z; Schultheis B; Hartmann F; Dogan A; Cetin C; Krentel H; Schiermeier S; Tempfer CB
Anticancer Res; 2016 Oct; 36(10):5365-5371. PubMed ID: 27798900
[TBL] [Abstract][Full Text] [Related]
13. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer.
Miglietta S; Girolimetti G; Marchio L; Sollazzo M; Laprovitera N; Coluccelli S; De Biase D; De Leo A; Santini D; Kurelac I; Iommarini L; Ghelli A; Campana D; Ferracin M; Perrone AM; Gasparre G; Porcelli AM
Noncoding RNA; 2022 Sep; 8(5):. PubMed ID: 36287116
[TBL] [Abstract][Full Text] [Related]
15. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
[TBL] [Abstract][Full Text] [Related]
16. A case of pulmonary type of ovarian small cell carcinoma.
Suzuki N; Kameyama K; Hirao T; Susumu N; Mukai M; Aoki D
J Obstet Gynaecol Res; 2007 Apr; 33(2):203-6. PubMed ID: 17441897
[TBL] [Abstract][Full Text] [Related]
17. Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.
Wang Y; Yang J; Yu M; Cao D; Zhang Y; Zong X; Shen K
Medicine (Baltimore); 2018 Aug; 97(33):e11838. PubMed ID: 30113473
[TBL] [Abstract][Full Text] [Related]
18. Small-cell carcinoma of the ovary with breast metastases: a case report.
Reckova M; Mego M; Rejlekova K; Sycova-Mila Z; Obertova Z; Mardiak J
Klin Onkol; 2010; 23(1):43-5. PubMed ID: 20192073
[TBL] [Abstract][Full Text] [Related]
19. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
20. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
Tkácová M; Vertaková-Krakovská B; Belohorská B; Miskovská V; Helpianska L; Ondrus D; Ondrusová M; Spánik S; Svec J
Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
